These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20879245)

  • 21. Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology.
    Belarbi K; Burnouf S; Fernandez-Gomez FJ; Laurent C; Lestavel S; Figeac M; Sultan A; Troquier L; Leboucher A; Caillierez R; Grosjean ME; Demeyer D; Obriot H; Brion I; Barbot B; Galas MC; Staels B; Humez S; Sergeant N; Schraen-Maschke S; Muhr-Tailleux A; Hamdane M; Buée L; Blum D
    Neurobiol Dis; 2011 Aug; 43(2):486-94. PubMed ID: 21569847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.
    Schindowski K; Bretteville A; Leroy K; Bégard S; Brion JP; Hamdane M; Buée L
    Am J Pathol; 2006 Aug; 169(2):599-616. PubMed ID: 16877359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo imaging of tau pathology using multi-parametric quantitative MRI.
    Wells JA; O'Callaghan JM; Holmes HE; Powell NM; Johnson RA; Siow B; Torrealdea F; Ismail O; Walker-Samuel S; Golay X; Rega M; Richardson S; Modat M; Cardoso MJ; Ourselin S; Schwarz AJ; Ahmed Z; Murray TK; O'Neill MJ; Collins EC; Colgan N; Lythgoe MF
    Neuroimage; 2015 May; 111():369-78. PubMed ID: 25700953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mouse models of Alzheimer's disease: the long and filamentous road.
    Phinney AL; Horne P; Yang J; Janus C; Bergeron C; Westaway D
    Neurol Res; 2003 Sep; 25(6):590-600. PubMed ID: 14503012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endogenous tau aggregates in oligodendrocytes of rTg4510 mice induced by human P301L tau.
    Ren Y; Lin WL; Sanchez L; Ceballos C; Polydoro M; Spires-Jones TL; Hyman BT; Dickson DW; Sahara N
    J Alzheimers Dis; 2014; 38(3):589-600. PubMed ID: 24028867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice.
    Grueninger F; Bohrmann B; Czech C; Ballard TM; Frey JR; Weidensteiner C; von Kienlin M; Ozmen L
    Neurobiol Dis; 2010 Feb; 37(2):294-306. PubMed ID: 19781645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assembly of paired helical filaments from mouse tau: implications for the neurofibrillary pathology in transgenic mouse models for Alzheimer's disease.
    Kampers T; Pangalos M; Geerts H; Wiech H; Mandelkow E
    FEBS Lett; 1999 May; 451(1):39-44. PubMed ID: 10356980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination with Sarkosyl insoluble PHF-tau decrease neurofibrillary tangles formation in aged tau transgenic mouse model: a pilot study.
    Ando K; Kabova A; Stygelbout V; Leroy K; Heraud C; Frédérick C; Suain V; Yilmaz Z; Authelet M; Dedecker R; Potier MC; Duyckaerts C; Brion JP
    J Alzheimers Dis; 2014; 40 Suppl 1():S135-45. PubMed ID: 24614899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced Tau Aggregation in the Presence of Amyloid β.
    Bennett RE; DeVos SL; Dujardin S; Corjuc B; Gor R; Gonzalez J; Roe AD; Frosch MP; Pitstick R; Carlson GA; Hyman BT
    Am J Pathol; 2017 Jul; 187(7):1601-1612. PubMed ID: 28500862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Home cage measures of Alzheimer's disease in the rTg4510 mouse model.
    Barabas AJ; Robbins LA; Gaskill BN
    Genes Brain Behav; 2022 Feb; 21(2):e12795. PubMed ID: 35044727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy.
    Blackmore T; Meftah S; Murray TK; Craig PJ; Blockeel A; Phillips K; Eastwood B; O'Neill MJ; Marston H; Ahmed Z; Gilmour G; Gastambide F
    Alzheimers Res Ther; 2017 Sep; 9(1):77. PubMed ID: 28931441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteomic profiling of brain cortex tissues in a Tau transgenic mouse model of Alzheimer's disease.
    Chang SH; Jung IS; Han GY; Kim NH; Kim HJ; Kim CW
    Biochem Biophys Res Commun; 2013 Jan; 430(2):670-5. PubMed ID: 23211594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a 3xTg-AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background.
    Virgili J; Lebbadi M; Tremblay C; St-Amour I; Pierrisnard C; Faucher-Genest A; Emond V; Julien C; Calon F
    Synapse; 2018 Apr; 72(4):. PubMed ID: 29341269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Striatum and entorhinal cortex atrophy in AD mouse models: MRI comprehensive analysis.
    Micotti E; Paladini A; Balducci C; Tolomeo D; Frasca A; Marizzoni M; Filibian M; Caroli A; Valbusa G; Dix S; O'Neill M; Ozmen L; Czech C; Richardson JC; Frisoni GB; Forloni G
    Neurobiol Aging; 2015 Feb; 36(2):776-88. PubMed ID: 25433456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenic tau species drive a psychosis-like phenotype in a mouse model of Alzheimer's disease.
    Koppel J; Jimenez H; Azose M; D'Abramo C; Acker C; Buthorn J; Greenwald BS; Lewis J; Lesser M; Liu Z; Davies P
    Behav Brain Res; 2014 Dec; 275():27-33. PubMed ID: 25151619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered function of hippocampal CA1 pyramidal neurons in the rTg4510 mouse model of tauopathy.
    Dalby NO; Volbracht C; Helboe L; Larsen PH; Jensen HS; Egebjerg J; Elvang AB
    J Alzheimers Dis; 2014; 40(2):429-42. PubMed ID: 24448785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amyloid precursor protein reduction enhances the formation of neurofibrillary tangles in a mutant tau transgenic mouse model.
    Vanden Dries V; Stygelbout V; Pierrot N; Yilmaz Z; Suain V; De Decker R; Buée L; Octave JN; Brion JP; Leroy K
    Neurobiol Aging; 2017 Jul; 55():202-212. PubMed ID: 28464981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
    Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy.
    Yue M; Hanna A; Wilson J; Roder H; Janus C
    Neurobiol Aging; 2011 Apr; 32(4):590-603. PubMed ID: 19427061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.